T cells migrate to tumour sites after extracorporeal interleukin 2 stimulation and reinfusion in a patient with metastatic melanoma

URN to cite this document:: urn:nbn:de:bvb:355-epub-211115
DOI to cite this document:: 10.5283/epub.21111

Dummer, R. ; Becker, J. C. ; Eilles, Christoph ; Schäfer, E. ; Börner, W. ; Burg, G.

Preview

PDF
(2MB)

Date of publication of this fulltext: 10 Jun 2011 07:48

Alternative links to fulltext:Pubmed

Details

Preview

Export bibliographical data

Abstract

Peripheral blood mononuclear cells (PBMC) were taken by leukapheresis from a patient with melanoma skin metastases and stimulated in vitro using 1000 IU recombinant interleukin 2 (IL-2)/ml to generate lymphokine-activated killer cells (LAK cells). Two-colour immunofluorescence analysis demonstrated an IL-2-induced up-regulation of CD25 on natural killer cells (CD56+) as well as on T lymphocytes ...